Insider Transactions in Q2 2025 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2025
|
Susan D. De Vore Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+20.7%
|
-
|
|
May 14
2025
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+5.5%
|
-
|
|
May 14
2025
|
Lewis Hay Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+4.96%
|
-
|
|
May 14
2025
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+11.15%
|
-
|
|
May 14
2025
|
Antonio F Neri Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+10.88%
|
-
|
|
May 14
2025
|
Ramiro G Peru Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+6.04%
|
-
|
|
May 14
2025
|
Ryan M. Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+8.35%
|
-
|
|
May 14
2025
|
Deanna D Strable Soethout Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+26.75%
|
-
|
|
May 14
2025
|
R Kerry Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+5.87%
|
-
|
|
Apr 24
2025
|
Mark Kaye EVP & CFO |
SELL
Open market or private sale
|
Direct |
4,588
-19.47%
|
$1,945,312
$424.82 P/Share
|